FIELD: medicine.
SUBSTANCE: present invention provides maintenance of homeostasis of organisms and concerns: agent for reducing expression IL-1β in the skin of object and for increasing of expression of redox associated factor in human epidermal cell. Agent can include kaempferol, where redox factor is selected from group, consisting of one or more of the number of thioredoxin, thioredoxin reductase, glutathione reductase and glutaredoxin. Agent can include extract of ginkgo leaves, obtained by dissolving 50 % ethanol extract of Ginkgo biloba L. leaves in 1,3-butyleneglycol, where redox-associated factor is thioredoxin and/or thioredoxin reductase. Agent can include extract of galanga Kaempferia galanga, prepared by extraction with 50 % 1,3-butyleneglycol, where redox-associated factor is selected from group consisting of one or more of the number of thioredoxin, thioredoxin reductase, glutathione reductase and glutaredoxin.
EFFECT: maintenance of homeostasis of organisms.
16 cl, 6 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING L-CYSTEINE USING BACTERIA OF ENTEROBACTERIACEAE FAMILY | 2010 |
|
RU2458981C2 |
| COMBINED REMEDY FOR IMPROVING THE FUNCTIONAL STATE OF THE BRAIN | 2021 |
|
RU2782672C1 |
| PROBIOTIC BACTERIA HAVING ANTIOXIDANT ACTIVITY AND USE THEREOF | 2011 |
|
RU2572698C2 |
| BIOLOGICALLY ACTIVE FOOD SUPPLEMENT FOR VISION CORRECTION AND PROPHYLAXIS OF VISION DISTORTION | 2001 |
|
RU2270583C2 |
| USING GINKGO BILOBA LEAF EXTRACT | 2008 |
|
RU2493865C2 |
| METHOD FOR MAKING GINKGO BILOBA EXTRACT, AND GINKGO BILOBA EXTRACT | 2006 |
|
RU2367459C2 |
| COMPOSITION FOR COMFIT MANUFACTURING | 2017 |
|
RU2650548C1 |
| COMPLEX FOR PREVENTION OF ORAL CAVITY OXIDATIVE STRESS | 2019 |
|
RU2748338C2 |
| NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE | 2012 |
|
RU2605287C2 |
| COLLECTION HAVING ANTIHYPOXIC AND HYPOTENSIVE ACTIONS | 2013 |
|
RU2587722C2 |
